StonvexLoading…
StonvexStonvexStonvexCore line items from TMO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-28 | Annual 2025 2025-12-31 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|---|
Revenue | $11.82B | $11.01B | $44.56B | $32.34B | $21.22B |
Operating Income | Not available | $1.86B | $7.75B | $5.49B | $3.55B |
Net Income | Not available | $1.65B | $6.70B | $4.74B | $3.12B |
EPS (Diluted) | $5.77 | $4.43 | $17.74 | $12.53 | $8.26 |
Total Assets | Not available | $113.28B | $110.34B | $103.02B | $101.23B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $3.25B | $9.85B | $1.98B | $4.58B |
Free Cash Flow OCF − CapEx | Not available | $816.00M | $6.29B | $3.30B | $1.47B |
Shares Outstanding | Not available | 373.00M | 378.00M | 378.00M | 378.00M |